Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD
Tris Pharma has formed the organization along with a licensing agreement with Braingaze for development, distribution of the technology.
Source: psychiatrictimes.com
James Hackworth News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from James Hackworth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In James Hackworth Today - Breaking & Trending Today
Tris Pharma Announces Acquisition of New, Late-Stage Drug Candidate for Pain
/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated, innovation-driven CNS company with a robust portfolio of FDA-approved products for the...
Source: prnewswire.com
Tris Pharma Announces Availability of New DYANAVEL® XR (amphetamine) Tablets for ADHD
/PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR...
Source: prnewswire.com
Tris Pharma Announces FDA Approval of DYANAVEL® XR (amphetamine) Once-Daily Extended-Release Oral Tablets, CII, for ADHD
/PRNewswire/ -- Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release...
Source: prnewswire.com
Tris Pharma® Announces Acquisition of Park Therapeutics - Pain Company with First-In-Class, Phase III-Ready New Chemical Entity (NCE)
Share this article Share this article MONMOUTH JUNCTION, N.J., April 29, 2021 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, today announced that it has acquired Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready. Studies have demonstrated the potential for the NCE to provide st...
Source: prnewswire.com